APO Research
Talk to an analyst

APO RESEARCH · REPORT

Drugs of Abuse Testing Systems

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Drugs of Abuse Testing Systems Market Outlook and Growth Opportunities 2026

4 July 2026199 pages

Choose your research edition.

Industry ResearchDrugs of Abuse Testing Systems Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Drugs of Abuse Testing Systems Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Drugs of Abuse Testing Systems Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Drugs of Abuse Testing Systems Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Drugs of Abuse Testing Systems Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Drugs of Abuse Testing Systems market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Drugs of Abuse Testing Systems is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Drugs of Abuse Testing Systems market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Drugs of Abuse Testing Systems market include Abbott, Thermo Fisher Scientific, Roche, Wondfo Biotech, Siemens Healthineers, Randox Laboratories, Orient Gene Biotech, OraSure and Intec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Drugs of Abuse Testing Systems market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Drugs of Abuse Testing Systems and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Drugs of Abuse Testing Systems sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Drugs of Abuse Testing Systems market size, projected growth trends, production technologies, key applications, and end-use industries.

Drugs of Abuse Testing Systems Segment by Company

Abbott

Thermo Fisher Scientific

Roche

Wondfo Biotech

Siemens Healthineers

Randox Laboratories

Orient Gene Biotech

OraSure

Intec

Hangzhou Biotest

Drager

Assure Tech (Hangzhou) Co

Aotai Bio

Drugs of Abuse Testing Systems Segment by Type

Urine Screening System

Saliva Test System

Others

Drugs of Abuse Testing Systems Segment by Application

Hospital

Laboratory

Others

Drugs of Abuse Testing Systems Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Drugs of Abuse Testing Systems status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Drugs of Abuse Testing Systems market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Drugs of Abuse Testing Systems significant trends, drivers, influence factors in global and regions.

6. To analyze Drugs of Abuse Testing Systems competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs of Abuse Testing Systems market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Drugs of Abuse Testing Systems and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs of Abuse Testing Systems.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Drugs of Abuse Testing Systems market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Drugs of Abuse Testing Systems industry.

Chapter 3: Detailed analysis of Drugs of Abuse Testing Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Drugs of Abuse Testing Systems in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Drugs of Abuse Testing Systems in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Drugs of Abuse Testing Systems Industry Trends Table 2. Drugs of Abuse Testing Systems Industry Drivers Table 3. Drugs of Abuse Testing Systems Industry Opportunities and Challenges Table 4. Drugs of Abuse Testing Systems Industry Restraints Table 5. Global Drugs of Abuse Testing Systems Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Drugs of Abuse Testing Systems Revenue Share by Company (2021-2026) Table 7. Global Drugs of Abuse Testing Systems Sales Volume by Company (k units) & (2021-2026) Table 8. Global Drugs of Abuse Testing Systems Sales Volume Share by Company (2021-2026) Table 9. Global Drugs of Abuse Testing Systems Average Price (USD/unit) of Company (2021-2026) Table 10. Global Drugs of Abuse Testing Systems Company Ranking, (2024-2026) & (USD Million) Table 11. Global Drugs of Abuse Testing Systems Key Company Manufacturing Base & Headquarters Table 12. Global Drugs of Abuse Testing Systems Company, Product Type & Application Table 13. Global Drugs of Abuse Testing Systems Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Drugs of Abuse Testing Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Urine Screening System Table 18. Significant Companies of Saliva Test System Table 19. Significant Companies of Others Table 20. Global Drugs of Abuse Testing Systems Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Drugs of Abuse Testing Systems Sales Volume by Type (2021-2026) & (k units) Table 22. Global Drugs of Abuse Testing Systems Sales Volume by Type (2027-2032) & (k units) Table 23. Global Drugs of Abuse Testing Systems Sales Volume Share by Type (2021-2026) Table 24. Global Drugs of Abuse Testing Systems Sales Volume Share by Type (2027-2032) Table 25. Global Drugs of Abuse Testing Systems Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Drugs of Abuse Testing Systems Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Drugs of Abuse Testing Systems Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Drugs of Abuse Testing Systems Sales Value Share by Type (2021-2026) Table 29. Global Drugs of Abuse Testing Systems Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospital Table 31. Significant Companies of Laboratory Table 32. Significant Companies of Others Table 33. Global Drugs of Abuse Testing Systems Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Drugs of Abuse Testing Systems Sales Volume by Application (2021-2026) & (k units) Table 35. Global Drugs of Abuse Testing Systems Sales Volume by Application (2027-2032) & (k units) Table 36. Global Drugs of Abuse Testing Systems Sales Volume Share by Application (2021-2026) Table 37. Global Drugs of Abuse Testing Systems Sales Volume Share by Application (2027-2032) Table 38. Global Drugs of Abuse Testing Systems Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Drugs of Abuse Testing Systems Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Drugs of Abuse Testing Systems Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Drugs of Abuse Testing Systems Sales Value Share by Application (2021-2026) Table 42. Global Drugs of Abuse Testing Systems Sales Value Share by Application (2027-2032) Table 43. Global Drugs of Abuse Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Drugs of Abuse Testing Systems Sales by Region (2021-2026) & (k units) Table 45. Global Drugs of Abuse Testing Systems Sales Market Share by Region (2021-2026) Table 46. Global Drugs of Abuse Testing Systems Sales by Region (2027-2032) & (k units) Table 47. Global Drugs of Abuse Testing Systems Sales Market Share by Region (2027-2032) Table 48. Global Drugs of Abuse Testing Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Drugs of Abuse Testing Systems Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Drugs of Abuse Testing Systems Sales Value Share by Region (2021-2026) Table 51. Global Drugs of Abuse Testing Systems Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Drugs of Abuse Testing Systems Sales Value Share by Region (2027-2032) Table 53. Global Drugs of Abuse Testing Systems Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global Drugs of Abuse Testing Systems Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global Drugs of Abuse Testing Systems Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Drugs of Abuse Testing Systems Sales by Country (2021-2026) & (k units) Table 58. Global Drugs of Abuse Testing Systems Sales Market Share by Country (2021-2026) Table 59. Global Drugs of Abuse Testing Systems Sales by Country (2027-2032) & (k units) Table 60. Global Drugs of Abuse Testing Systems Sales Market Share by Country (2027-2032) Table 61. Global Drugs of Abuse Testing Systems Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Drugs of Abuse Testing Systems Sales Value Market Share by Country (2021-2026) Table 63. Global Drugs of Abuse Testing Systems Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Drugs of Abuse Testing Systems Sales Value Market Share by Country (2027-2032) Table 65. Abbott Company Information Table 66. Abbott Business Overview Table 67. Abbott Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. Abbott Drugs of Abuse Testing Systems Product Portfolio Table 69. Abbott Recent Development Table 70. Thermo Fisher Scientific Company Information Table 71. Thermo Fisher Scientific Business Overview Table 72. Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio Table 74. Thermo Fisher Scientific Recent Development Table 75. Roche Company Information Table 76. Roche Business Overview Table 77. Roche Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Roche Drugs of Abuse Testing Systems Product Portfolio Table 79. Roche Recent Development Table 80. Wondfo Biotech Company Information Table 81. Wondfo Biotech Business Overview Table 82. Wondfo Biotech Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio Table 84. Wondfo Biotech Recent Development Table 85. Siemens Healthineers Company Information Table 86. Siemens Healthineers Business Overview Table 87. Siemens Healthineers Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio Table 89. Siemens Healthineers Recent Development Table 90. Randox Laboratories Company Information Table 91. Randox Laboratories Business Overview Table 92. Randox Laboratories Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio Table 94. Randox Laboratories Recent Development Table 95. Orient Gene Biotech Company Information Table 96. Orient Gene Biotech Business Overview Table 97. Orient Gene Biotech Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio Table 99. Orient Gene Biotech Recent Development Table 100. OraSure Company Information Table 101. OraSure Business Overview Table 102. OraSure Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. OraSure Drugs of Abuse Testing Systems Product Portfolio Table 104. OraSure Recent Development Table 105. Intec Company Information Table 106. Intec Business Overview Table 107. Intec Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Intec Drugs of Abuse Testing Systems Product Portfolio Table 109. Intec Recent Development Table 110. Hangzhou Biotest Company Information Table 111. Hangzhou Biotest Business Overview Table 112. Hangzhou Biotest Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio Table 114. Hangzhou Biotest Recent Development Table 115. Drager Company Information Table 116. Drager Business Overview Table 117. Drager Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. Drager Drugs of Abuse Testing Systems Product Portfolio Table 119. Drager Recent Development Table 120. Assure Tech (Hangzhou) Co Company Information Table 121. Assure Tech (Hangzhou) Co Business Overview Table 122. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio Table 124. Assure Tech (Hangzhou) Co Recent Development Table 125. Aotai Bio Company Information Table 126. Aotai Bio Business Overview Table 127. Aotai Bio Drugs of Abuse Testing Systems Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. Aotai Bio Drugs of Abuse Testing Systems Product Portfolio Table 129. Aotai Bio Recent Development Table 130. Key Raw Materials Table 131. Raw Materials Key Suppliers Table 132. Drugs of Abuse Testing Systems Distributors List Table 133. Drugs of Abuse Testing Systems Customers List Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Drugs of Abuse Testing Systems Product Image Figure 2. Global Drugs of Abuse Testing Systems Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 4. Global Drugs of Abuse Testing Systems Sales (2021-2032) & (k units) Figure 5. Global Drugs of Abuse Testing Systems Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Drugs of Abuse Testing Systems Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Urine Screening System Image Figure 10. Saliva Test System Image Figure 11. Others Image Figure 12. Global Drugs of Abuse Testing Systems Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Drugs of Abuse Testing Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Drugs of Abuse Testing Systems Sales Volume Share by Type (2021-2032) Figure 15. Global Drugs of Abuse Testing Systems Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Drugs of Abuse Testing Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Drugs of Abuse Testing Systems Sales Value Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Laboratory Image Figure 20. Others Image Figure 21. Global Drugs of Abuse Testing Systems Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Drugs of Abuse Testing Systems Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Drugs of Abuse Testing Systems Sales Volume Share by Application (2021-2032) Figure 24. Global Drugs of Abuse Testing Systems Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Drugs of Abuse Testing Systems Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Drugs of Abuse Testing Systems Sales Value Share by Application (2021-2032) Figure 27. Global Drugs of Abuse Testing Systems Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global Drugs of Abuse Testing Systems Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Drugs of Abuse Testing Systems Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Drugs of Abuse Testing Systems Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 32. North America Drugs of Abuse Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Drugs of Abuse Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Drugs of Abuse Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 38. South America Drugs of Abuse Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Drugs of Abuse Testing Systems Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Drugs of Abuse Testing Systems Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Drugs of Abuse Testing Systems Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Drugs of Abuse Testing Systems Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Urine Screening System
  • Saliva Test System
  • Others
Applications
  • Hospital
  • Laboratory
  • Others
Companies covered
  • Abbott
  • Thermo Fisher Scientific
  • Roche
  • Wondfo Biotech
  • Siemens Healthineers
  • Randox Laboratories
  • Orient Gene Biotech
  • OraSure
  • Intec
  • Hangzhou Biotest
  • Drager
  • Assure Tech (Hangzhou) Co
  • Aotai Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Drugs of Abuse Testing Systems Sales Value (2021-2032)
  4. 1.2.2 Global Drugs of Abuse Testing Systems Sales Volume (2021-2032)
  5. 1.2.3 Global Drugs of Abuse Testing Systems Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Drugs of Abuse Testing Systems Market Dynamics
  1. 2.1 Drugs of Abuse Testing Systems Industry Trends
  2. 2.2 Drugs of Abuse Testing Systems Industry Drivers
  3. 2.3 Drugs of Abuse Testing Systems Industry Opportunities and Challenges
  4. 2.4 Drugs of Abuse Testing Systems Industry Restraints
3 Drugs of Abuse Testing Systems Market by Company
  1. 3.1 Global Drugs of Abuse Testing Systems Company Revenue Ranking in 2025
  2. 3.2 Global Drugs of Abuse Testing Systems Revenue by Company (2021-2026)
  3. 3.3 Global Drugs of Abuse Testing Systems Sales Volume by Company (2021-2026)
  4. 3.4 Global Drugs of Abuse Testing Systems Average Price by Company (2021-2026)
  5. 3.5 Global Drugs of Abuse Testing Systems Company Ranking (2024-2026)
  6. 3.6 Global Drugs of Abuse Testing Systems Company Manufacturing Base and Headquarters
  7. 3.7 Global Drugs of Abuse Testing Systems Company Product Type and Application
  8. 3.8 Global Drugs of Abuse Testing Systems Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Drugs of Abuse Testing Systems Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Drugs of Abuse Testing Systems Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Drugs of Abuse Testing Systems Market by Type
  1. 4.1 Drugs of Abuse Testing Systems Type Introduction
  2. 4.1.1 Urine Screening System
  3. 4.1.2 Saliva Test System
  4. 4.1.3 Others
  5. 4.2 Global Drugs of Abuse Testing Systems Sales Volume by Type
  6. 4.2.1 Global Drugs of Abuse Testing Systems Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Drugs of Abuse Testing Systems Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Drugs of Abuse Testing Systems Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Drugs of Abuse Testing Systems Sales Value by Type
  10. 4.3.1 Global Drugs of Abuse Testing Systems Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Drugs of Abuse Testing Systems Sales Value by Type (2021-2032)
  12. 4.3.3 Global Drugs of Abuse Testing Systems Sales Value Share by Type (2021-2032)
5 Drugs of Abuse Testing Systems Market by Application
  1. 5.1 Drugs of Abuse Testing Systems Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Laboratory
  4. 5.1.3 Others
  5. 5.2 Global Drugs of Abuse Testing Systems Sales Volume by Application
  6. 5.2.1 Global Drugs of Abuse Testing Systems Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Drugs of Abuse Testing Systems Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Drugs of Abuse Testing Systems Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Drugs of Abuse Testing Systems Sales Value by Application
  10. 5.3.1 Global Drugs of Abuse Testing Systems Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Drugs of Abuse Testing Systems Sales Value by Application (2021-2032)
  12. 5.3.3 Global Drugs of Abuse Testing Systems Sales Value Share by Application (2021-2032)
6 Drugs of Abuse Testing Systems Regional Sales and Value Analysis
  1. 6.1 Global Drugs of Abuse Testing Systems Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Drugs of Abuse Testing Systems Sales by Region (2021-2032)
  3. 6.2.1 Global Drugs of Abuse Testing Systems Sales by Region: 2021-2026
  4. 6.2.2 Global Drugs of Abuse Testing Systems Sales by Region (2027-2032)
  5. 6.3 Global Drugs of Abuse Testing Systems Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Drugs of Abuse Testing Systems Sales Value by Region (2021-2032)
  7. 6.4.1 Global Drugs of Abuse Testing Systems Sales Value by Region: 2021-2026
  8. 6.4.2 Global Drugs of Abuse Testing Systems Sales Value by Region (2027-2032)
  9. 6.5 Global Drugs of Abuse Testing Systems Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Drugs of Abuse Testing Systems Sales Value (2021-2032)
  12. 6.6.2 North America Drugs of Abuse Testing Systems Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Drugs of Abuse Testing Systems Sales Value (2021-2032)
  15. 6.7.2 Europe Drugs of Abuse Testing Systems Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Drugs of Abuse Testing Systems Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Drugs of Abuse Testing Systems Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Drugs of Abuse Testing Systems Sales Value (2021-2032)
  21. 6.9.2 South America Drugs of Abuse Testing Systems Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Drugs of Abuse Testing Systems Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Drugs of Abuse Testing Systems Sales Value Share by Country, 2025 VS 2032
7 Drugs of Abuse Testing Systems Country-level Sales and Value Analysis
  1. 7.1 Global Drugs of Abuse Testing Systems Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Drugs of Abuse Testing Systems Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Drugs of Abuse Testing Systems Sales by Country (2021-2032)
  4. 7.3.1 Global Drugs of Abuse Testing Systems Sales by Country (2021-2026)
  5. 7.3.2 Global Drugs of Abuse Testing Systems Sales by Country (2027-2032)
  6. 7.4 Global Drugs of Abuse Testing Systems Sales Value by Country (2021-2032)
  7. 7.4.1 Global Drugs of Abuse Testing Systems Sales Value by Country (2021-2026)
  8. 7.4.2 Global Drugs of Abuse Testing Systems Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Drugs of Abuse Testing Systems Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Drugs of Abuse Testing Systems Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Drugs of Abuse Testing Systems Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott
  2. 8.1.1 Abbott Company Information
  3. 8.1.2 Abbott Business Overview
  4. 8.1.3 Abbott Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Drugs of Abuse Testing Systems Product Portfolio
  6. 8.1.5 Abbott Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Drugs of Abuse Testing Systems Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Roche Drugs of Abuse Testing Systems Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Wondfo Biotech
  20. 8.4.1 Wondfo Biotech Company Information
  21. 8.4.2 Wondfo Biotech Business Overview
  22. 8.4.3 Wondfo Biotech Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wondfo Biotech Drugs of Abuse Testing Systems Product Portfolio
  24. 8.4.5 Wondfo Biotech Recent Developments
  25. 8.5 Siemens Healthineers
  26. 8.5.1 Siemens Healthineers Company Information
  27. 8.5.2 Siemens Healthineers Business Overview
  28. 8.5.3 Siemens Healthineers Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Siemens Healthineers Drugs of Abuse Testing Systems Product Portfolio
  30. 8.5.5 Siemens Healthineers Recent Developments
  31. 8.6 Randox Laboratories
  32. 8.6.1 Randox Laboratories Company Information
  33. 8.6.2 Randox Laboratories Business Overview
  34. 8.6.3 Randox Laboratories Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Randox Laboratories Drugs of Abuse Testing Systems Product Portfolio
  36. 8.6.5 Randox Laboratories Recent Developments
  37. 8.7 Orient Gene Biotech
  38. 8.7.1 Orient Gene Biotech Company Information
  39. 8.7.2 Orient Gene Biotech Business Overview
  40. 8.7.3 Orient Gene Biotech Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Orient Gene Biotech Drugs of Abuse Testing Systems Product Portfolio
  42. 8.7.5 Orient Gene Biotech Recent Developments
  43. 8.8 OraSure
  44. 8.8.1 OraSure Company Information
  45. 8.8.2 OraSure Business Overview
  46. 8.8.3 OraSure Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 OraSure Drugs of Abuse Testing Systems Product Portfolio
  48. 8.8.5 OraSure Recent Developments
  49. 8.9 Intec
  50. 8.9.1 Intec Company Information
  51. 8.9.2 Intec Business Overview
  52. 8.9.3 Intec Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Intec Drugs of Abuse Testing Systems Product Portfolio
  54. 8.9.5 Intec Recent Developments
  55. 8.10 Hangzhou Biotest
  56. 8.10.1 Hangzhou Biotest Company Information
  57. 8.10.2 Hangzhou Biotest Business Overview
  58. 8.10.3 Hangzhou Biotest Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Hangzhou Biotest Drugs of Abuse Testing Systems Product Portfolio
  60. 8.10.5 Hangzhou Biotest Recent Developments
  61. 8.11 Drager
  62. 8.11.1 Drager Company Information
  63. 8.11.2 Drager Business Overview
  64. 8.11.3 Drager Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Drager Drugs of Abuse Testing Systems Product Portfolio
  66. 8.11.5 Drager Recent Developments
  67. 8.12 Assure Tech (Hangzhou) Co
  68. 8.12.1 Assure Tech (Hangzhou) Co Company Information
  69. 8.12.2 Assure Tech (Hangzhou) Co Business Overview
  70. 8.12.3 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Assure Tech (Hangzhou) Co Drugs of Abuse Testing Systems Product Portfolio
  72. 8.12.5 Assure Tech (Hangzhou) Co Recent Developments
  73. 8.13 Aotai Bio
  74. 8.13.1 Aotai Bio Company Information
  75. 8.13.2 Aotai Bio Business Overview
  76. 8.13.3 Aotai Bio Drugs of Abuse Testing Systems Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Aotai Bio Drugs of Abuse Testing Systems Product Portfolio
  78. 8.13.5 Aotai Bio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Drugs of Abuse Testing Systems Value Chain Analysis
  2. 9.1.1 Drugs of Abuse Testing Systems Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Drugs of Abuse Testing Systems Sales Mode & Process
  6. 9.2 Drugs of Abuse Testing Systems Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Drugs of Abuse Testing Systems Distributors
  9. 9.2.3 Drugs of Abuse Testing Systems Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst